4//SEC Filing
Lingamneni Anila 4
Accession 0001127602-24-020383
CIK 0000313143other
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 4:27 PM ET
Size
6.2 KB
Accession
0001127602-24-020383
Insider Transaction Report
Form 4
Lingamneni Anila
EVP, Chief Technology Officer
Transactions
- Sale
Common Stock
2024-07-11$90.00/sh−2,136$192,240→ 21,410 total - Sale
Common Stock
2024-07-12$90.00/sh−79$7,110→ 21,331 total
Footnotes (2)
- [F1]Transaction pursuant to an existing 10b5-1 trading plan dated March 13, 2024 (fully executed as of March 13, 2024).
- [F2]This number includes unvested restricted stock units previously reported.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001808414
Filing Metadata
- Form type
- 4
- Filed
- Jul 14, 8:00 PM ET
- Accepted
- Jul 15, 4:27 PM ET
- Size
- 6.2 KB